Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Baudax Bio Inc

BXRX
Current price
0.033 USD -0.0014 USD (-4.12%)
Last closed 0.034 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 421 135 USD
Yield for 12 month -99.12 %
Week
Month
Year
BXRX
21.11.2021 - 28.11.2021

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2019 and is based in Malvern, Pennsylvania. Address: 490 Lapp Road, Malvern, PA, United States, 19355

Analytics

WallStreet Target Price

24 USD

P/E ratio

Dividend Yield

Current Year

+1 269 000 USD

Last Year

+1 080 000 USD

Current Quarter

Last Quarter

+30 000 USD

Current Year

-5 740 000 USD

Last Year

-1 365 000 USD

Current Quarter

-43 000 USD

Last Quarter

-74 000 USD

Key Figures BXRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -34 761 000 USD
Operating Margin TTM -2759.89 %
PE Ratio
Return On Assets TTM -114.93 %
PEG Ratio
Return On Equity TTM -4704.21 %
Wall Street Target Price 24 USD
Revenue TTM 1 269 000 USD
Book Value -0.84 USD
Revenue Per Share TTM 0.32 USD
Dividend Share
Quarterly Revenue Growth YOY -22.5 %
Dividend Yield
Gross Profit TTM -5 740 000 USD
Earnings Share -94.13 USD
Diluted Eps TTM -94.13 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics BXRX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BXRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:40
Payout Ratio
Last Split Date 01.12.2022
Dividend Date

Stock Valuation BXRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 7.2144
Price Sales TTM 1.1199
Enterprise Value EBITDA -0.2794
Price Book MRQ 0.6815

Financials BXRX

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators BXRX

For 52 weeks

0.031 USD 6.58 USD
50 Day MA 0.2 USD
Shares Short Prior Month 35 678
200 Day MA 0.76 USD
Short Ratio 0.19
Shares Short 493 562
Short Percent 5.17 %